Skip to main content
Clinical Trials/NCT04037800
NCT04037800CompletedNot Applicable

Impact of Sustainable Functional Urethral Reconstruction on Early Continence Recovery After Robotic-assisted Radical Prostatectomy: a Randomized Controlled Trial

Changhai Hospital1 site in 1 country96 target enrollmentStarted: December 8, 2019Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
96
Locations
1
Primary Endpoint
1-month urinary continence recovery rates

Study Overview

Brief Summary

The study is a prospective randomized controlled trail to compare early urinary continence recovery after robotic-assisted radical prostatectomy with or without sustainable functional urethral reconstruction (SFUR).

Detailed Description

Early urinary incontinence has always been a tricky problem for both patients and urologists, even though over 90% patients can recover 1 year after surgery. Many urologists are trying to modify the surgical technique to resolve this problem. Sustainable functional urethral reconstruction (SFUR) is a novel technique which may improve early urinary continence recovery for both local and locally advanced prostate cancer, and even for those with high volume prostate by providing adequate urethral length with bladder neck tubularization and making sustainable periurethral support with peritoneal flap. The purpose of this study is to verify the impact of this new technique on early recovery of urinary continence, as well as on urinary function and oncological outcomes.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Participant, Outcomes Assessor)

Eligibility Criteria

Ages
40 Years to 75 Years (Adult, Older Adult)
Sex
Male
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •≥40, but ≤75 years old;
  • •Histological confirmed prostate cancer;
  • •Localized or locally advanced prostate cancer;
  • •Presence of urinary continence prior to the procedure;
  • •Informed consent signed;

Exclusion Criteria

  • •Metastatic prostate cancer confirmed by ECT, PSMA or whole-body MRI;
  • •Presence of any prostatic surgery(such as transurethral resection, laser therapy, microwave therapy, radiofrequency ablation and so on) prior to the procedure;
  • •Radiation therapy of the prostate or pelvis prior to the procedure;
  • •Uncontrolled intercurrent illness that would limit compliance with study requirements;
  • •Any condition that contraindicates a radical prostatectomy;

Arms & Interventions

SFUR-RARP

Experimental

Patients in which RARP with sustainable functional urethral reconstruction (SFUR) is performed.

Intervention: SFUR-RARP (Procedure)

Standard RARP

Active Comparator

Patients in which standard RARP is performed.

Intervention: Standard RARP (Procedure)

Outcomes

Primary Outcomes

1-month urinary continence recovery rates

Time Frame: 1 month after catheter removal

Continence defined as daily usage of 0-1 pad with 24-hour pad weights≤50g.

Secondary Outcomes

  • Short-term urinary continence recovery(Within 3 month after catheter removal)
  • Peri and postoperative complications(1-year follow up)
  • Post-operative oncological outcomes(1-year follow up)
  • Short-term urinary function and urinary function-related quality of life(1-week, 2-week, 1-month, 3-month after catheter removal.)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Yinghao Sun

Chief Physician

Changhai Hospital

Study Sites (1)

Loading locations...

Similar Trials